UC Faculty Protest Elsevier by Suspending Work for Cell Press

More than 30 professors will no longer serve on editorial boards of the journals unless Elsevier and the University of California can reach a contract.

Written byKerry Grens
| 2 min read
berkeley elsevier scholarly publishing cell press university of california open access

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: Nine of the professors who signed the letter are at the University of California, Berkeley.
© ISTOCK.COM, ALANTOBEY

Faculty members at a number University of California schools have stopped serving on the editorial boards of journals published by Cell Press in protest of its parent company, Elsevier, not having reached a deal with UC for access to its publications. The 31 signatories of a letter to Elsevier, posted yesterday (August 7) online, write that unless Elsevier and UC can agree upon a new contract, they will not serve on the boards of Cell, Neuron, Immunity, Current Biology, and others.

“This is a way of drawing attention to the issue,” Matthew Welch, a UC Berkeley molecular and cell biologist who helped draft the letter, says in a press release. He had served on the editorial board of Cell. “This is not going to affect the day-to-day operation of the journals in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies